| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/18/2012 | CN102579518A Pterocephalus hookeri (C.B.Clarke) Hoeck total saponin extract and preparation method and application thereof |
| 07/18/2012 | CN102579501A Full-ingredient uniform freeze-drying preparation for royal jelly and production method for full-ingredient uniform freeze-drying preparation |
| 07/18/2012 | CN102579441A Application of mycoepoxydiene nicotinic acids derivatives in preparation process of pro-inflammatory mediator inhibitors |
| 07/18/2012 | CN102579427A Synthetic lactone formulations and method of use |
| 07/18/2012 | CN102579384A Allopurinol slow-release micro pill tablet and preparation method thereof |
| 07/18/2012 | CN102579340A Sinomenine vesicle and preparation and preparation method thereof |
| 07/18/2012 | CN102228649B Quality control method for Shufeng Huoluo tablets |
| 07/18/2012 | CN102166343B Medicine for treating fracture and caput femoris necrosis and preparation method thereof |
| 07/18/2012 | CN102139003B Plaster for treating furuncle and joint swelling and heat and application thereof |
| 07/18/2012 | CN102028768B Traditional Chinese medicament for treating lumbar canal stenosis |
| 07/18/2012 | CN102000276B External plaster for promoting blood circulation and removing blood stasis and preparation method thereof |
| 07/18/2012 | CN101940587B Xanthan-gum-containing pharmaceutical preparation for joint intracavity injection |
| 07/18/2012 | CN101912536B Medicinal composition for treating rheumatism and rheumatoid disease |
| 07/18/2012 | CN101880283B Azaindole kinase inhibitors |
| 07/18/2012 | CN101843630B Composite containing iridoid compound and application thereof |
| 07/18/2012 | CN101829125B Compound combined formulation for preventing and treating osteoarthrosis and preparation method thereof |
| 07/18/2012 | CN101775058B Preparation and application of pharmaceutical preparation of 11-carbonyl-betal- acetyl mastic acid and derivatives thereof extracted from frankincense |
| 07/18/2012 | CN101693051B Preparation method and composition of clerodendranthus spicatus extract |
| 07/18/2012 | CN101653451B Health product for keeping joint health and increasing bone density and preparation method thereof |
| 07/18/2012 | CN101647805B Glucosamine chewable tablet used for relieving and preventing osteoarthritis and preparation method thereof |
| 07/18/2012 | CN101642442B Tablets for preventing and curing osteoarthritis and preparation method thereof |
| 07/18/2012 | CN101590169B Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 07/18/2012 | CN101590168B Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 07/18/2012 | CN101590167B Traditional Chinese medicine combination for treating gout and preparation method thereof |
| 07/18/2012 | CN101579367B Medicinal dripping pill for treating rickets |
| 07/18/2012 | CN101516881B 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 07/18/2012 | CN101501038B Fused [d]pyridazin-7-ones |
| 07/18/2012 | CN101475484B Synthesizing method and use of bone-targeted antiphlogistic medicament |
| 07/18/2012 | CN101433544B External-use pharmaceutical composition formulation with antiphlogistic, swelling-dispersing and analgesic functions, and use |
| 07/18/2012 | CN101386604B Aromatic nitrile-base thiazole derivatives for inhibiting xanthine oxidase activity, preparation method and application |
| 07/18/2012 | CN101048160B Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 07/17/2012 | US8222405 Phenylalanine derivatives |
| 07/17/2012 | US8222384 Modified and stabilized GDF propeptides and uses thereof |
| 07/17/2012 | US8222244 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 07/17/2012 | US8221773 Hydrogels and uses thereof |
| 07/17/2012 | US8221757 Monoclonal antibodies against extracellular loops of C5aR |
| 07/17/2012 | CA2718348C Orally administered peptides to ameliorate atherosclerosis |
| 07/17/2012 | CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates |
| 07/17/2012 | CA2519189C Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
| 07/17/2012 | CA2517372C Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation |
| 07/17/2012 | CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof |
| 07/17/2012 | CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof |
| 07/12/2012 | WO2012094671A2 Modular extracorporeal systems and methods for treating blood-borne diseases |
| 07/12/2012 | WO2012094636A2 Chemosensory receptor ligand-based therapies |
| 07/12/2012 | WO2012094511A2 Compositions and methods for the treatment of orthopedic disease or injury |
| 07/12/2012 | WO2012092645A1 Novel antisense oligonucleotides |
| 07/12/2012 | US20120178820 Method for treating arthritis |
| 07/12/2012 | US20120178781 Kappa opioid receptor ligands |
| 07/12/2012 | US20120178778 Pyrazolopyridines |
| 07/12/2012 | US20120178770 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors |
| 07/12/2012 | US20120178758 Styryl-triazine derivatives and their therapeutical applications |
| 07/12/2012 | US20120178753 Inhibitors of bruton's tyrosine kinase |
| 07/12/2012 | US20120178752 Rho kinase inhibitors |
| 07/12/2012 | US20120178747 Compositions and methods for bone formation and remodeling |
| 07/12/2012 | US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase |
| 07/12/2012 | US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 07/12/2012 | US20120178736 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use |
| 07/12/2012 | US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 07/12/2012 | US20120178718 Novel imidazolidine compounds as androgen receptor modulators |
| 07/12/2012 | US20120178714 Phosphorus-containing Compounds & Uses Thereof |
| 07/12/2012 | US20120178713 Phenyl sulphonamides as modulators of ion channels |
| 07/12/2012 | US20120178712 Phytochemical compositions including sesamin for anti-inflammatory, anti-cytokine storm, and other uses |
| 07/12/2012 | US20120178706 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside |
| 07/12/2012 | US20120178684 Surgical Calcium Phosphate Citrate-Containing Cement and Method of Manufacturing the Same |
| 07/12/2012 | US20120178669 Protease inhibitors, compositions and methods of use |
| 07/12/2012 | US20120178668 Proteinaceous compounds and uses therefor |
| 07/12/2012 | US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 07/12/2012 | US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/12/2012 | US20120177754 Inhibitor of inflammatory conditions |
| 07/12/2012 | US20120177752 Nutritional compositions including beta-hydroxy-beta-methylbutyrate |
| 07/12/2012 | US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof |
| 07/12/2012 | US20120177739 Delayed Release Tablet with Defined Core Geometry |
| 07/12/2012 | US20120177704 Crystalline anti-human il-12 antibodies |
| 07/12/2012 | US20120177702 Solid Forms for Tissue Repair |
| 07/12/2012 | US20120177689 Generation of novel bone forming cells (monoosteophils) from ll-37 treated monocytes |
| 07/12/2012 | US20120177655 Anti-human il-21 monoclonal antibodies |
| 07/12/2012 | US20120177654 Method of treatment and agents useful for same |
| 07/12/2012 | US20120177647 Mdl-1 uses |
| 07/12/2012 | US20120177644 Mesenchymal stem cell differentiation |
| 07/12/2012 | US20120177633 Methods for accelerating the healing of connective tissue injuries and disorders |
| 07/12/2012 | US20120177619 Composition comprising a haematic component and its use for the treatment of degenerative joint disease |
| 07/12/2012 | US20120177618 Hematopoietic stromal progenitor cells and uses thereof |
| 07/12/2012 | US20120177616 Methods for augmentation collection of placental hematopoietic stem cells and uses thereof |
| 07/12/2012 | US20120177602 Dissolution aids for oral peptide delivery comprising a biguanide |
| 07/12/2012 | US20120177600 Compositions and Methods for Inducing or Enhancing Connective Tissue Repair |
| 07/12/2012 | US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 07/12/2012 | US20120177593 Synthesis of dendrimer conjugates |
| 07/11/2012 | EP2474327A1 Microdosing of ultrasound contrast agents |
| 07/11/2012 | EP2474237A1 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 07/11/2012 | EP1979316B1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
| 07/11/2012 | EP1472224B1 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 07/11/2012 | EP1470121B1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/11/2012 | CN202314489U 一种治疗颈椎病的外用黑膏药贴 A treatment for cervical spondylosis topical patch to black |
| 07/11/2012 | CN1900074B Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/11/2012 | CN102574890A Certain chemical entities, compositions, and methods |
| 07/11/2012 | CN102574879A Targetted drug delivery to the bone |
| 07/11/2012 | CN102574844A Maleic acid salt and crystal thereof |
| 07/11/2012 | CN102573887A Osteolysis treatment |
| 07/11/2012 | CN102573867A Compositions for treating degenerative joint diseases |
| 07/11/2012 | CN102573849A Medicinal composition for iontophoresis |